SEARCH BY
Try For Free 7-Day Free Trial
ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.
DEAL STATS | # |
---|---|
Overall | 31 of 36 |
Sector (Medical Products) | 9 of 9 |
Type (Going Private) | 2 of 3 |
State (Wisconsin) | 2 of 2 |
Country (United States) | 7 of 9 |
Year (2022) | 3 of 4 |
Size (of disclosed) | 1 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-07-12 |
Title21
Phoenix, Arizona, United States Title21 is a provider of paperless electronic services to cell & gene therapy labs. Title21’s clients include globally preeminent hospital and research institutions, including the Mayo Clinic, Memorial Sloan Kettering Cancer Center, Stanford University, Kaiser Permanente, and the University of Pennsylvania Health System. The fast-growing cell & gene therapy industry is transforming the treatment of life-threatening conditions including genetic disorders like spinal muscular atrophy, and diseases caused by vital infection, including COVID-19. Title21 was formed in 2001 and is based in Pleasanton, California. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-08-08 |
Bomi Group
Spino d’Adda, Italy Bomi Group runs cutting-edge transport, warehousing, and supply chain management services for healthcare companies ranging from pharmaceutical and medical equipment manufacturers to hospitals, testing laboratories, and outpatient service providers. Bomi Group was formed in `1985 and is based in Spino d’Adda, Italy. |
Sell | - |